Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. (Q51576091)
Jump to navigation
Jump to search
scientific article published in April 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. |
scientific article published in April 1997 |
Statements
1 reference
Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. (English)
1 reference
E M Velazquez
1 reference
S G Mendoza
1 reference
P Wang
1 reference
C J Glueck
1 reference
1 April 1997
1 reference
1 reference
46
1 reference
454-457
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference